Molbio Diagnostics IPO
The Molbio Diagnostics IPO was a ₹939.70 crore mainboard issue (fresh issue and offer for sale), open for bidding from 10 Aug to 12 August 2026 at a price band of ₹768 to ₹807. The final issue price was ₹807. It was subscribed 70.26 times overall, and 12.96 times in the retail category. Shares listed on NSE and BSE on 17 August 2026 at ₹980.00, 21.4% above the issue price, and closed the first day at ₹1,041.70.
- Listing gain at open
- +21.4%₹980.00 vs ₹807
- Issue price
- ₹807Band ₹768 to ₹807
- Lot size
- 18 sharesMinimum ₹14,526
- Issue size
- ₹939.70 crore
- Subscribed
- 70.26xOverall
- Listed
- 17 Aug 2026NSE, BSE
Price and lots
Molbio Diagnostics IPO details
NSE issue details| Bidding dates | 10 Aug 2026 to 12 Aug 2026 |
| Listing date | 17 August 2026 |
| Price band | ₹768 to ₹807 |
| Final issue price | ₹807 |
| Face value | ₹1 per share |
| Lot size | 18 shares |
| Minimum investment | ₹14,526 (18 shares, our calculation) |
| Retail maximum | 13 lots (₹1,88,838), under ₹2 lakh (our calculation) |
| Issue size | ₹939.70 crore (our calculation from the NSE issue details) |
| Type of issue | 100% Book Building, Fresh issue and offer for sale |
| Employee discount | ₹76 per share |
| Listed on | NSE and BSE |
| NSE symbol | MOLBIO |
| BSE code | 544866 |
| ISIN | INE869T01028 |
| Lead managers | Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited |
| Registrar | KFin Technologies Limited |
Subscription and listing
Molbio Diagnostics IPO subscription and listing
NSE and BSEFinal subscription
NSE issue details- QIBs186.39x
- Non-institutional (NII)49.80x
- NII above ₹10 lakh50.82x
- NII ₹2 lakh to ₹10 lakh47.76x
- Retail12.96x
- Employees13.28x
- Total70.26x
Times subscribed at the close of bidding, as published by NSE. It is a fact about demand, not a sign of quality.
Listing day
Our calculation: gains vs issue price| NSE | BSE | |
|---|---|---|
| Open | ₹980.00 | ₹980.00 |
| High | ₹1,064.75 | - |
| Low | ₹926.35 | - |
| Close | ₹1,041.70 | ₹1,036.30 |
| Gain at open | +21.4% | +21.4% |
| Gain at close | +29.1% | +28.4% |
| Shares traded | 1,59,77,892 | - |
Latest: closed at ₹1,339.30 on NSE on 6 November 2026, +66.0% vs the issue price (our calculation). Past returns say nothing about future returns.
How it compares
How the Molbio Diagnostics IPO compares
Our calculation: 2026 mainboard IPOs on IPO24by7Among 109 mainboard IPOs of 2026 on our tracker, the Molbio Diagnostics IPO's subscription of 70.26 times ranks 36th of 109, and its listing gain of 21.4% at open ranks 30th of 107. By issue size it ranks 33rd. The median listing-day gain at open for mainboard IPOs this year is +7.6%. See all 2026 IPOs with listing gains or the IPO calendar for August 2026.
Other mainboard IPOs listed in August 2026
| IPO | Listed | Issue price | Subscribed | Gain at open |
|---|---|---|---|---|
| Augmont Enterprises | 31 Aug 2026 | ₹788 | 105.78x | +22.0% |
| Tempsens Instruments (India) | 28 Aug 2026 | ₹300 | 184.07x | +111.3% |
| Gaja Alternative Asset Management | 26 Aug 2026 | ₹160 | 31.33x | +15.6% |
| Shankesh Jewellers | 25 Aug 2026 | ₹93 | 2.80x | +11.1% |
| Sunshine Pictures | 25 Aug 2026 | ₹360 | 105.81x | +10.0% |
| Horizon Industrial Parks | 24 Aug 2026 | ₹60 | 1.45x | +0.4% |
Allotment
Molbio Diagnostics IPO allotment status
- Open the registrar's pageKFin Technologies Limited is the registrar. Open its allotment page.
- Select Molbio Diagnostics LimitedOlder issues may move to an archive list on the registrar's site.
- Enter your PAN, application number or DP IDUse the details you applied with.
- Or check your demat accountAllotted shares were credited before the listing day.
Documents
Questions
Molbio Diagnostics IPO FAQs
What was the Molbio Diagnostics IPO price band?
The price band was ₹768 to ₹807 per share and the final issue price was ₹807. The face value is ₹1 per share.
What was the Molbio Diagnostics IPO lot size?
One lot was 18 shares. The minimum investment at the issue price was ₹14,526. Retail investors could apply for up to 13 lots.
How many times was the Molbio Diagnostics IPO subscribed?
It was subscribed 70.26 times overall, as published by NSE. QIBs bid 186.39 times their quota, NIIs 49.80 times and retail investors 12.96 times.
What was the Molbio Diagnostics IPO listing price?
It opened at ₹980.00 on NSE and BSE on 17 August 2026, a gain of 21.4% over the issue price of ₹807 (our calculation). It closed the day at ₹1,041.70.
How do I check Molbio Diagnostics IPO allotment status?
KFin Technologies Limited is the registrar. Select Molbio Diagnostics Limited on its allotment page and enter your PAN, application number or DP ID. You can also check on the NSE or BSE application status page.
Was the Molbio Diagnostics IPO a fresh issue or an offer for sale?
Fresh issue and offer for sale, as stated in the NSE issue details.
Who were the lead managers of the Molbio Diagnostics IPO?
Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited.
Sources: NSE public issue information and IPO detail pages; NSE and BSE end-of-day bhavcopy files. Gains, issue size and minimum investment are our calculations. This page is information only, not a recommendation.